-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Serial Number
Product Name
Application Areas
Packaging Specifications
P-Phenylenedimethanesulfonic acid
β-Nicotinamide mononucleotide
Phenethylresorcinol
4-Butylresorcinol
1,2-Hexanediol
1,2-Pentanediol
1,3-Butanediol
ε-polylysine
ε-polylysine hydrochloride
Steroid drug intermediate -- dihydrocholesterol (BA)
Poly-L-lactic acid
Polycaprolactone
Hexyl 2-(diethylamino)benzoylbenzoate
Methylene bis-benzotriazolyl tetramethylbutylphenol
Bis-ethylhexyloxyphenol methoxyphenyl triazine
Ocrelizumab
Ethylhexyl triazone
Glyceryl glucoside
Sodium hyaluronate
Bisabolol
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline